Variations in target volume definition and dose to normal tissue using anatomic versus biological imaging (18F‐FDG‐PET) in the treatment of bone metastases: results from a 3‐arm randomized phase II trial
暂无分享,去创建一个
W. De Neve | I. Goethals | P. Ost | I. Madani | B. Speleers | B. Lambert | D. Berwouts | Katrien De Wolf | L. Olteanu
[1] Els Goetghebeur,et al. Biological 18[F]-FDG-PET image-guided dose painting by numbers for painful uncomplicated bone metastases: A 3-arm randomized phase II trial. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[2] You Lu,et al. Primary Tumor Standardized Uptake Value Measured on F18-Fluorodeoxyglucose Positron Emission Tomography Is of Prediction Value for Survival and Local Control in Non–Small-Cell Lung Cancer Receiving Radiotherapy , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[3] K. Sugimura,et al. Prognostic Value of FDG PET Imaging in Patients with Laryngeal Cancer , 2014, PloS one.
[4] J. Deasy,et al. Estimate of the impact of FDG-avidity on the dose required for head and neck radiotherapy local control , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[5] J. Buscombe,et al. PET imaging of inflammation. , 2014, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[6] Nick Jagiella,et al. Estimating Dose Painting Effects in Radiotherapy: A Mathematical Model , 2014, PloS one.
[7] D. Loeffelbein,et al. Performance of Whole-Body Integrated 18F-FDG PET/MR in Comparison to PET/CT for Evaluation of Malignant Bone Lesions , 2014, The Journal of Nuclear Medicine.
[8] M. Adli,et al. FDG PET uptake as a predictor of pain response in palliative radiation therapy in patients with bone metastasis. , 2013, Radiology.
[9] Xiaoyuan Chen,et al. PET Imaging of Inflammation Biomarkers , 2013, Theranostics.
[10] R. Maxwell,et al. Variation in radiotherapy target volume definition, dose to organs at risk and clinical target volumes using anatomic (computed tomography) versus combined anatomic and molecular imaging (positron emission tomography/computed tomography): intensity-modulated radiotherapy delivered using a tomotherap , 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).
[11] Scott Soltys,et al. International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. , 2012, International journal of radiation oncology, biology, physics.
[12] Y. M. van der Linden,et al. Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. , 2012, International journal of radiation oncology, biology, physics.
[13] P. Brown,et al. Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial. , 2012, The Lancet. Oncology.
[14] L. Zeng,et al. Update on the systematic review of palliative radiotherapy trials for bone metastases. , 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).
[15] J. Flickinger,et al. Clinical practice of image-guided spine radiosurgery - results from an international research consortium , 2011, Radiation oncology.
[16] L. Rhines,et al. Irradiation of spinal metastases: should we continue to include one uninvolved vertebral body above and below in the radiation field? , 2011, International journal of radiation oncology, biology, physics.
[17] Fang-Fang Yin,et al. RTOG 0631 Phase II/III Study of Image-Guided Stereotactic Radiosurgery for Localized (1-3) Spine Metastases: Phase II Results. , 2011, International journal of radiation oncology, biology, physics.
[18] Yong Xu,et al. Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy , 2011, European Radiology.
[19] Dianfu Li,et al. Comparison of 18F-FDG PET/CT with bone scintigraphy for detection of bone metastasis: a meta-analysis , 2011, Acta radiologica.
[20] Vincent Gregoire,et al. Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription. , 2011, Seminars in radiation oncology.
[21] F. Calabria,et al. Metabolic and clinical assessment of efficacy of cryoablation therapy on skeletal masses by 18F-FDG positron emission tomography/computed tomography (PET/CT) and visual analogue scale (VAS): initial experience , 2011, Skeletal Radiology.
[22] Sunil Krishnan,et al. Targeting inflammatory pathways for tumor radiosensitization. , 2010, Biochemical pharmacology.
[23] A R Hounsell,et al. Geometrical analysis of radiotherapy target volume delineation: a systematic review of reported comparison methods. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).
[24] A. Scarsbrook,et al. FDG PET/CT in oncology: "raising the bar". , 2010, Clinical radiology.
[25] Z. Fu,et al. Prognostic value of 18F-FDG PET/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[26] E. Yorke,et al. Use of normal tissue complication probability models in the clinic. , 2010, International journal of radiation oncology, biology, physics.
[27] Ehud Mendel,et al. A Novel Classification System for Spinal Instability in Neoplastic Disease: An Evidence-Based Approach and Expert Consensus From the Spine Oncology Study Group , 2009, Spine.
[28] Liying Zhang,et al. Determining the incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: results from three canadian cancer centers. , 2009, International journal of radiation oncology, biology, physics.
[29] John Whitehead,et al. One‐ and two‐stage design proposals for a phase II trial comparing three active treatments with control using an ordered categorical endpoint , 2009, Statistics in medicine.
[30] F. Stewart,et al. Milestones in normal tissue radiation biology over the past 50 years: From clonogenic cell survival to cytokine networks and back to stem cell recovery , 2009, International journal of radiation biology.
[31] P. Allavena,et al. Cancer-related inflammation , 2008, Nature.
[32] J. Rock,et al. Pain control by image-guided radiosurgery for solitary spinal metastasis. , 2008, Journal of pain and symptom management.
[33] C. Cleeland,et al. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. , 2007, Journal of neurosurgery. Spine.
[34] James M Galvin,et al. Intensity modulating and other radiation therapy devices for dose painting. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] S. Bentzen. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology , 2006, Nature Reviews Cancer.
[36] H. Thierens,et al. [18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[37] C. Rübe,et al. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[38] T. Boterberg,et al. Pain control by ionizing radiation of bone metastasis. , 2004, The International journal of developmental biology.
[39] E. Noordijk,et al. Comparative analysis of risk factors for pathological fracture with femoral metastases. , 2004, The Journal of bone and joint surgery. British volume.
[40] Jingeng Zhu,et al. Image‐guided and intensity‐modulated radiosurgery for patients with spinal metastasis , 2003, Cancer.
[41] T. Reichert,et al. Radiation response non-invasively imaged by [18F]FDG-PET predicts local tumor control and survival in advanced oral squamous cell carcinoma. , 2003, Oral oncology.
[42] B. Jeremic,et al. A randomized trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain. , 1998, International journal of radiation oncology, biology, physics.
[43] H. Lam,et al. Single fraction conventional external beam radiation therapy for bone metastases: a systematic review of randomised controlled trials. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[44] R. Riesenburger. A Novel Classification System for Spinal Instability in Neoplastic Disease: An Evidence-Based Approach and Expert Consensus From the Spine Oncology Study Group , 2011 .